Radient Technologies EBITDA margin
Was ist das EBITDA margin von Radient Technologies?
EBITDA margin von Radient Technologies, Inc. ist -133.64%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Industrials Sektor auf TSXV im Vergleich zu Radient Technologies
Was macht Radient Technologies?
Radient Technologies Inc., together with its subsidiaries, processes, sells, and distributes cannabis materials in Canada. It offers cannabis oil, standardized cannabinoid ingredients, cannabis extracts, and cannabis formulations. The company also provides extraction services for the extraction, purification, and isolation of cannabinoids for third parties. Its ingredients are used in natural food and beverage products, personal care products, and nutraceutical and pharmaceutical products. Radient Technologies Inc. was incorporated in 2001 and is headquartered in Edmonton, Canada.
Unternehmen mit ebitda margin ähnlich Radient Technologies
- ContextLogic hat EBITDA margin von -134.80%
- Outset Medical hat EBITDA margin von -134.68%
- Nanoco Plc hat EBITDA margin von -134.13%
- Majedie Investments Plc hat EBITDA margin von -134.11%
- Bryah Resources hat EBITDA margin von -133.96%
- Puhui Wealth Investment Management Co hat EBITDA margin von -133.96%
- Radient Technologies hat EBITDA margin von -133.64%
- BNY Mellon High Yield Strategies Fund hat EBITDA margin von -133.54%
- HTC Purenergy hat EBITDA margin von -133.47%
- HTC Purenergy hat EBITDA margin von -133.47%
- Vivoryon Therapeutics AG hat EBITDA margin von -133.43%
- Vivoryon Therapeutics AG hat EBITDA margin von -133.43%
- Vivoryon Therapeutics N.V hat EBITDA margin von -133.43%